Search results
Iteris, Inc. (NASDAQ:ITI) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoIteris, Inc. (NASDAQ:ITI) Q3 2023 Earnings Call Transcript February 2, 2023 Operator: Good day and...
Unexpected Headwinds Affected Iteris (ITI)’s Q2 Performance
Insider Monkey via Yahoo Finance· 7 months agoLiberty Park Capital Management, LLC, a financial management company, released its second quarter...
Iteris (ITI) Q4 2022 Earnings Call Transcript
Motley Fool· 2 years agoGood afternoon, everyone, and thank you for participating in today's conference call to discuss Iteris' financial results for its 2022 fiscal fourth...
Is Iteris, Inc. (NASDAQ:ITI) Trading At A 38% Discount?
Simply Wall St. via Yahoo Finance· 7 months agoKey Insights Iteris' estimated fair value is US$6.69 based on 2 Stage Free Cash Flow to Equity...
Iteris Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 11 months agoIteris (NASDAQ:ITI) Full Year 2023 Results Key Financial Results Revenue: US$156.1m (up 17% from FY...
Iteris (NASDAQ:ITI) shareholders have earned a 50% return over the last year
Simply Wall St. via Yahoo Finance· 1 year agoThe simplest way to invest in stocks is to buy exchange traded funds. But you can significantly...
Iteris (ITI) Reports Q4 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoIteris (ITI) delivered earnings and revenue surprises of -225% and 0.07%, respectively, for the...
Investors in Iteris (NASDAQ:ITI) have unfortunately lost 24% over the last three years
Simply Wall St. via Yahoo Finance· 1 month agoIn order to justify the effort of selecting individual stocks, it's worth striving to beat the...
An Intrinsic Calculation For Iteris, Inc. (NASDAQ:ITI) Suggests It's 35% Undervalued
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Iteris' estimated fair value is US$7.00 based on 2 Stage Free Cash Flow to Equity...
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q3 2023 Earnings Call Transcript November 2, 2023...